PFIZER LIMITED

Active
Company number 00526209Private limited companyIncorporated 1953

Key figures

£983,988,000-34.4%
Net assets 2024/25
-34.4%
Average annual change 2023/24–2024/25
0500 m1 bn1.5 bn2 bn2023/242024/25

† PFIZER LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.

Ratios

2024/25

Sector comparison

SIC 46460

Where the company stands among the 2,974 active companies whose first SIC code is 46460 (Wholesale of pharmaceutical goods).

Turnover£576,260,000
Higher than 95% · median £23,764,000 among 214 that publish turnover
Net assets£983,988,000
Higher than 99% · median £32,520
Total assets£1,124,768,000
Higher than 99% · median £255,000
Employees1,154
Higher than 99% · median 1
Company age73.0 years
Older than 99% · median 6.2 years
Largest in this sector by net assets
  1. CSL BEHRING HOLDINGS LIMITED£11bn
  2. VIIV HEALTHCARE UK LIMITED£5.7bn
  3. MCKESSON GLOBAL SOURCING LIMITED£1bn
  4. MCKESSON MEDICAL-SURGICAL SOURCING LIMITED£999.5m
  5. PFIZER LIMITED£984m
  6. ABBOTT LABORATORIES LIMITED£871.8m
  7. GLAXOSMITHKLINE UK LIMITED£779m
  8. UNIKERIS LIMITED£642m
  9. HALEON UK TRADING LIMITED£554.8m
  10. MUNDIPHARMA MEDICAL COMPANY LIMITED£461.7m

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 2,974. The line on each bar marks the median.

Summary: PFIZER LIMITED

What kind of company is it?

PFIZER LIMITED is a private limited company registered with Companies House under company number 00526209. It was incorporated on 27 Nov 1953. Its status is active. The registered office is in Kent (CT13). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), other research and experimental development on natural sciences and engineering (72190).

How is the company doing financially?

The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files full accounts. Turnover was £576,260,000. Profit for the year was £31,687,000. Net assets were £983,988,000, down 34.4% on the previous year. Total assets were £1,124,768,000 and total liabilities £424,000. The company had an average of 1,154 employees. Figures are available for 2 financial years (2023/24–2024/25).

How does it compare with similar companies?

Compared with 2,974 active companies whose first SIC code is 46460: By turnover it ranks higher than 95% of the 214 that publish turnover (median £23,764,000). By net assets it ranks higher than 99% of them (median £32,520). By total assets it ranks higher than 99% of them (median £255,000). By number of employees it ranks higher than 99% of them (median 1). It is older than 99% of them (median age 6.2 years).

Does it supply the public sector?

The company is named as a supplier in 160 public contract award notices from 26 public sector buyers since 2016. Contracts awarded to it alone have a combined published value of £580.4m. Its most frequent buyer is NHS England (68 contracts). 83 of the awards are shared with other suppliers, typically framework agreements.

What do public registers and reports show?

It appears on the Home Office register of licensed sponsors (Global Business Mobility: Senior or Specialist Worker, Skilled Worker). HMRC lists it as an importer of goods, mainly pharmaceuticals, organic chemicals, optical, medical and measuring instruments. HMRC lists it as an exporter of goods, mainly pharmaceuticals, electrical equipment, optical, medical and measuring instruments. In its latest payment practices report it took an average of 41 days to pay suppliers, and 8% of invoices were not paid within agreed terms. Its gender pay gap report for 2025/26 shows median hourly pay for women 14.1% lower than for men.

Who runs and controls the company?

One person with significant control is registered.

When are its next filings due?

The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 13 Jul 2027.

Filed accounts2023/24–2024/25
2023/24 †2024/25 †
Turnover—576,260,000
Profit for the year551,149,00031,687,000
Total assets1,843,125,0001,124,768,000
Total liabilities430,459,000424,000
Net assets / total equity1,500,370,000983,988,000
Average number of employees1,2431,154

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Public contracts

160 contracts

PFIZER LIMITED is named as a supplier in 160 public contract award notices from 26 public sector buyers since 2016. The 21 contracts awarded to it alone with a published value add up to £580.4m. 83 awards are shared with other suppliers and not counted in that total.

Contracts per year
Main buyers26
NHS England
68 contracts · £526m
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
20 contracts · £1.4m
Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on beha…
10 contracts · £20.4m
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the…
8 contracts
The NHS Commissioning Board (operating under the name of NHS England)
8 contracts
Latest 100 contracts
  1. LSL/MED/0228 Supply of Pfizer Pharmaceutical ProductsLEIDOS SUPPLY, LIMITED · £4,500,000 · runs until Oct 2029
  2. NHS National Framework for TafamidisNHS England · shared by 2 suppliers, up to £62,393,000 in total · runs until May 2028
  3. SARS-CoV-2 Adult Vaccine Supply (2027)‡UK Health Security Agency · £1 · runs until Dec 2027
  4. SARS-CoV-2 Adult Vaccine Supply (2027)‡Secretary of State for Health and Social Care acting as part of the Crown through UK Heal… · £1
  5. NHS National Generic Pharmaceuticals - Wave 16a‡NHS England · shared by 101 suppliers, up to £414,358,050 in total · 2 lots · runs until Jan 2029
Show 95 more
  1. NP49426a Transition Medicines‡The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PS… · shared by 6 suppliers, up to £2,514,000 in total
  2. Contraceptive Medicines‡The Common Services Agency (more commonly known as Public Services Delivery Scotland (PSD… · shared by 5 suppliers, up to £676,978 in total · 2 lots
  3. NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026‡NHS England · shared by 25 suppliers, up to £1,330,779,176 in total · 2 lots · runs until Aug 2028
  4. Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation, Procurement and Logistics Service · £977,459
  5. NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026‡NHS England · shared by 25 suppliers, up to £1,627,727,168 in total · 2 lots · runs until Aug 2028
  6. Under-18 SARS-CoV-2 Vaccine Supply (2026)‡UK Health Security Agency · £1 · runs until Aug 2027
  7. NHS National Branded Interim - 1 June 2026‡NHS England · shared by 51 suppliers, up to £529,090,780 in total · runs until Apr 2028
  8. NP36126 Antibiotic & Genito Urinary Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 38 suppliers, up to £36,398,668 in total
  9. Generic Drugs – Injections/Infusions 2‡NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University… · shared by 17 suppliers, up to £5,857,450 in total · runs until Jun 2027
  10. NHS National Generic Pharmaceuticals - Wave 15c‡NHS England · shared by 104 suppliers, up to £440,862,000 in total · 2 lots · runs until May 2028
  11. NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("the… · shared by 37 suppliers, up to £15,957,588 in total
  12. NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products‡NHS England · shared by 8 suppliers, up to £642,698,512 in total · 2 lots · runs until Feb 2028
  13. Family Planning Requisites‡NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University… · shared by 5 suppliers, up to £6,823,524 in total · runs until Jan 2029
  14. NHS National Framework for Generics HousekeepingNHS England · shared by 35 suppliers, up to £39,406,040 in total · 2 lots · runs until Sep 2027
  15. NP41125 Immunosuppressant Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 7 suppliers, up to £3,437,024 in total
  16. NP30925 Psychiatry and Neurology Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 33 suppliers, up to £7,031,939 in total · 2 lots
  17. NHS National Framework for Transition products (Axitinib and Eltrombopag)NHS England · shared by 7 suppliers, up to £52,385,000 in total · runs until Jan 2027
  18. NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025‡NHS England · shared by 21 suppliers, up to £986,282,758 in total · runs until Aug 2027
  19. NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025‡NHS England · £1
  20. Gastrointestinal, Endocrine, Nutrition & Blood Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 30 suppliers, up to £28,861,104 in total
  21. Aseptics Medicines (Including Cytotoxics)‡Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on beha… · £3,900,572
  22. NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National‡NHS England · shared by 28 suppliers, up to £261,895,933 in total · runs until Aug 2027
  23. NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025‡NHS England · £1
  24. Infant and Paediatric SARS-CoV-2 Vaccine Supply (2025)‡UK Health Security Agency · £1
  25. Infant and Paediatric SARS-CoV-2 Vaccine Supply (2025)‡UK Health Security Agency · £2 · 2 lots
  26. Proprietary Drugs‡eTenderwales · £12,596,000
  27. NHS National Generic Pharmaceuticals Wave 15b‡NHS England · £3 · 3 lots
  28. Medicinal Products and Pharma Funded Homecare [5749446]‡Regional Business Services Organisation Procurement and Logistics Service · shared by 31 suppliers, up to £210,000,000 in total
  29. NP34925g Anti-human T lymphocyte immunoglobulin (equine)‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · £1,398,600
  30. Biologic and Biosimilar Medicines‡eTenderwales · £5,690,000
  31. NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products‡NHS England · shared by 31 suppliers, up to £11,656,086 in total · runs until May 2027
  32. NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025‡NHS England · £1
  33. NP35925 Cardiovascular & Respiratory Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 33 suppliers, up to £54,899,950 in total · 2 lots
  34. NHS Framework Agreement for Branded Medicines - Proprietary Category Tender‡NHS England · shared by 72 suppliers, up to £1,241,520,444 in total · runs until Apr 2029
  35. NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025‡NHS England · £1
  36. NP47924 Cytokine Modulators‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 3 suppliers, up to £1,700,000 in total
  37. NP39724 Generic and Biosimilar Cancer Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 24 suppliers, up to £5,440,907 in total · 4 lots
  38. NP49024 Growth Hormone‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 4 suppliers, up to £15,751,000 in total · 2 lots
  39. Pneumococcal vaccine for adults and at risk groups (2025)‡UK Health Security Agency · £1 · runs until Apr 2029
  40. Pneumococcal vaccine for adults and at risk (2025)‡Secretary of State for Health and Social Care acting as part of the Crown through UK Heal… · £1
  41. NHS National Generic Pharmaceuticals Wave 15a‡NHS England · £2 · 2 lots
  42. NHS Branded Medicines Tranche Framework for London and South of England‡NHS England · £1
  43. Generic Drugs - Injections/Infusions‡Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on beha… · £564,588
  44. Medicinal Products Distribution and Associated Services [5009879]‡Procurement and Logistics Service · shared by 2 suppliers, up to £481,250,000 in total
  45. Heparins & Anticoagulants‡Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of… · £5,570,880
  46. Contracts for the supply of RSV immunisations‡UK Health Security Agency · £1 · runs until Jun 2028
  47. RSV Immunisations (2024)‡Secretary of State for Health and Social Care acting as part of the Crown through UK Heal… · £2 · 2 lots
  48. NHS Framework - Blood Disorders including Haemophilia A and B - July 2024‡NHS England · £2 · 2 lots
  49. NP36124 Antibiotic, Antiviral & Genito Urinary Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 35 suppliers, up to £24,453,828 in total · 2 lots
  50. NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024‡NHS England · £1
  51. NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)‡NHS England · shared by 63 suppliers, up to £1 in total · runs until May 2027
  52. NHS National Generic Pharmaceuticals Wave 14c‡NHS England · £3 · 3 lots
  53. NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("the… · shared by 33 suppliers, up to £24,244,455 in total
  54. Pneumococcal conjugate vaccine (PCV) 2024‡UK Health Security Agency · £1 · runs until Jul 2028
  55. Pneumococcal conjugate vaccine (PCV) 2024‡Secretary of State for Health and Social Care acting as part of the Crown through UK Heal… · £1
  56. Generic Drugs - Tablets and Capsules‡Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on beh… · £8,611
  57. Generic Anti-Infective Drugs‡Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on beha… · £14,277
  58. NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024‡NHS England · £4 · 4 lots
  59. NP30923 Psychiatry and Neurology Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · shared by 20 suppliers, up to £4,688,568 in total
  60. NHS South of England Branded Medicines - Tranche A - September 2023‡NHS England · £2 · 2 lots
  61. CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins‡NHS England · shared by 8 suppliers, up to £186,609,000 in total
  62. NHS National Framework for low molecular weight heparin products and fondaparinux‡NHS England · £1
  63. NHS London Branded Medicines - Tranche B - September 2023‡NHS England · £2 · 2 lots
  64. NHS National Generic Pharmaceuticals Wave 14b‡ATAMIS LTD · shared by 99 suppliers, up to £428,226,984 in total
  65. NHS National Generic Pharmaceuticals Wave 14b‡NHS England · £2 · 2 lots
  66. NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · shared by 42 suppliers, up to £24,339,430 in total · 2 lots
  67. NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals‡NHS England · shared by 50 suppliers, up to £304,504,000 in total
  68. NP35923 Cardiovascular & Respiratory Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · shared by 39 suppliers, up to £32,340,938 in total · 2 lots
  69. NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals‡NHS England · £2 · 2 lots
  70. NHS North of England Branded Medicines Tranche A & Annual Tranche‡NHS England · £2 · 2 lots
  71. NHS Midland & East Branded Medicines, Tranche B & Annual Tranche‡NHS England · shared by 35 suppliers, up to £480,429,000 in total
  72. NHS Framework for Midland & East Branded Medicines, Tranche B & Annual Tranche‡NHS England · £2 · 2 lots
  73. NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche‡NHS England · shared by 29 suppliers, up to £261,970,000 in total
  74. Generic and Biosimilar Cancer Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("the… · shared by 23 suppliers, up to £19,744,493 in total · 3 lots
  75. NP36722 Fertility Products‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("the… · shared by 2 suppliers, up to £285,555 in total
  76. NHS National Generic Pharmaceuticals Wave 14a‡NHS England · £2 · 2 lots
  77. NHS National Pharmaceuticals Transition 2022_2‡NHS England · £1
  78. NP41422 Contraceptive Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("the… · shared by 6 suppliers, up to £5,770,619 in total · 2 lots
  79. LSL/MED/0135 - Supply of Pfizer Branded Pharmaceuticals‡Ministry of Defence, DE&S, LDOC, CMO Commercial
  80. NHS National Pharmaceuticals Transition 2022_1‡NHS England and NHS Improvement · shared by 42 suppliers, up to £79,272,690 in total · 2 lots
  81. NHS National Pharmaceuticals Transition 2022_1‡NHS England · £1
  82. NHS Framework Agreement for South of England Branded - Tranche B and Annual‡NHS England · £2 · 2 lots
  83. NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual‡NHS England · £2 · 2 lots
  84. Proprietary Drugs‡Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on beha… · £5,193,146
  85. Bleeding Disorders including Haemophilia B‡NHS England · shared by 8 suppliers, up to £500,000,000 in total · 2 lots
  86. NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B‡NHS England · £1
  87. NHS Framework Agreement for Branded Medicines - National Tender‡NHS England · £1
  88. Antibiotic, Antiviral & Genito Urinary Medicines‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · shared by 35 suppliers, up to £34,267,240 in total · 2 lots
  89. Generic Drugs - Tablets & Capsules‡Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on beha… · £65,753
  90. NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual‡NHS England · shared by 31 suppliers, up to £216,078,796 in total
  91. NHS Framework for the North of England, Branded Medicine‡NHS England · shared by 31 suppliers, up to £716,741,676 in total · 3 lots
  92. NHS Framework for the North of England, Branded Medicine‡The NHS Commissioning Board (operating under the name of NHS England) · £2 · 2 lots
  93. NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual‡The NHS Commissioning Board (operating under the name of NHS England) · £2 · 2 lots
  94. Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("the… · shared by 31 suppliers, up to £12,381,386 in total
  95. Additional PF-07321332 Supply Agreement for Pandemic Purposes‡Department of Health and Social Care · £2 · 2 lots

From contract award notices on Contracts Finder (since 2016) and Find a Tender (since 2021), published by the Cabinet Office under the Open Government Licence v3.0. Values are as published by the buyer and usually cover the whole contract term; the total leaves out awards shared between several suppliers, where the published figure is a ceiling for all of them, placeholder values and single figures of £1 billion or more. Notices marked ‡ do not state a company number and were linked by an exact match on the registered name. Contracts below the publication thresholds and those of devolved buyers that publish elsewhere are not included.

Statutory reporting

Payment practices1 Dec 2025 – 31 May 2026
Average time taken to pay invoices
41 days
Invoices not paid within agreed terms
8%
Member of a payment code
No
  • Within 30 days 19%
  • 31 to 60 days 78%
  • After 60 days 3%
Earlier periods (7)
Period ending
Days to pay
Within 30 days
Late
30 Nov 2025
38
24%
10%
31 May 2025
40
18%
9%
30 Nov 2024
34
26%
0%
31 May 2024
37
18%
2%
30 Nov 2023
39
22%
1%
31 May 2023
39
17%
0%
30 Nov 2022
38
21%
0%

View the latest report on GOV.UK

Gender pay gap2025/26
Median hourly pay
women 14.1% lower
Mean hourly pay
women 15.6% lower
Median bonus pay
women 28.1% lower
Employer size
1000 to 4999 employees
Lower pay quarter69% womenLower middle62% womenUpper middle49.6% womenUpper pay quarter43.2% women
Earlier years (8)
Year
Median hourly pay
Mean hourly pay
2024/25
women 13.8% lower
women 16.5% lower
2023/24
women 13.8% lower
women 17.6% lower
2022/23
women 17.4% lower
women 19.8% lower
2021/22
women 17.2% lower
women 20.4% lower
2020/21
women 17.7% lower
women 19.2% lower
2019/20
women 26% lower
women 26.1% lower
2018/19
women 21.3% lower
women 24.8% lower
2017/18
women 17.6% lower
women 18.7% lower

A positive gap means women's average hourly pay is lower than men's across the whole employer; it is not a comparison of pay for the same work. View on the Gender pay gap service

Figures the company reported itself to the government's Check payment practices service, Gender pay gap service and Modern slavery statement registry (Open Government Licence v3.0). Only large companies and employers with 250 or more staff have to report, so most companies have nothing here.

Registers and licences

Sponsor licence‡
Licence type and rating
Worker (A rating)
Routes
Global Business Mobility: Senior or Specialist Worker, Skilled Worker

On the Home Office register of licensed sponsors, which lists organisations licensed to sponsor workers from overseas.

International trade‡

Listed by HMRC as an importer of goods in 12 of the last 12 months on record, most recently August 2026. Main goods: pharmaceuticals, organic chemicals, optical, medical and measuring instruments, plastics and miscellaneous chemicals.

Listed by HMRC as an exporter of goods in 12 of the last 12 months on record, most recently August 2026. Main goods: pharmaceuticals, electrical equipment, optical, medical and measuring instruments, perfumery and cosmetics and soaps and waxes.

From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.

Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.

History

4 events
  1. Financial year 2024/25 endedAccounts: turnover £576.3m, net assets £984m, 1,154 employees
  2. Financial year 2023/24 endedAccounts: net assets £1.5bn, 1,243 employees
  3. Pfizer Inc registered as a person with significant control
  4. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.